Cancer-Causing Proteins Greensboro NC

The drugs, called thiazole antibiotics, appear to block a cellular protein called FoxM1, one of the most over-produced proteins in cancer cells, according to researchers at the University of Illinois at Chicago College of Medicine. FoxM1 is believed to play an important role in causing cells to become cancerous and may present a promising target for future anti-cancer treatments.

Peter Rubin
(336) 832-1100
501 N Elam Ave
Greensboro, NC
Specialty
Internal Medicine, Medical Oncology

Data Provided by:
Peter Robert Ennever
(336) 832-1100
501 N Elam Ave
Greensboro, NC
Specialty
Hematology, Hematology / Oncology, Medical Oncology

Data Provided by:
Peter Rubin, MD
(336) 832-1100
501 N Elam Ave
Greensboro, NC
Specialties
Oncology (Cancer), Internal Medicine
Gender
Male
Education
Medical School: Univ Of Calgary, Fac Of Med, Calgary, Alb, Canada
Graduation Year: 1988

Data Provided by:
Mohamed Kamel Mohamed
(336) 832-1100
501 N Elam Ave
Greensboro, NC
Specialty
Internal Medicine, Medical Oncology

Data Provided by:
Firas N Shadad
(336) 832-1100
501 N Elam Ave
Greensboro, NC
Specialty
Hematology / Oncology

Data Provided by:
Richard James Rosen
(336) 832-8062
1200 N Elm St
Greensboro, NC
Specialty
Internal Medicine, Hematology / Oncology

Data Provided by:
Kalsoom Kausar Khan
(336) 832-1100
501 N Elam Ave
Greensboro, NC
Specialty
Internal Medicine, Medical Oncology

Data Provided by:
Matthew A Manning, MD
(336) 832-1100
501 N Elam Ave
Greensboro, NC
Specialties
Oncology (Cancer), Radiation Oncology
Gender
Male
Education
Medical School: Va Commonwealth Univ, Med Coll Of Va Sch Of Med, Richmond Va 23298
Graduation Year: 1996

Data Provided by:
John Emerson Feldmann, MD
(336) 832-0820
501 N Elam Ave
Greensboro, NC
Specialties
Oncology (Cancer), Hematology-Internal Medicine
Gender
Male
Education
Medical School: Cornell Univ Med Coll, New York Ny 10021
Graduation Year: 1968

Data Provided by:
Gary Bradley Sherrill
(336) 832-1100
501 N Elam Ave
Greensboro, NC
Specialty
Internal Medicine, Hematology / Oncology

Data Provided by:
Data Provided by:

Cancer-Causing Proteins

Provided By:

Scientists are closer to understanding how a recently approved class of antibiotics may work against cancer.

The drugs, called thiazole antibiotics, appear to block a cellular protein called FoxM1, one of the most over-produced proteins in cancer cells, according to researchers at the University of Illinois at Chicago College of Medicine. FoxM1 is believed to play an important role in causing cells to become cancerous and may present a promising target for future anti-cancer treatments.

The researchers also found that thiazoles may inhibit proteasomes, a molecular complex within cells that disposes of old proteins marked for destruction. Recently, a number of proteasome inhibitors have shown promise against cancer. One of these inhibitors, bortezomib (Velcade), has proven effective against a number of cancers, including myeloma and certain forms of lymphoma.

The new research, which appears in the online journal PLoS ONE, points to the possible anti-cancer use of thiazoles in the future. In a university news release, study author Andrei Gartel, an associate professor of molecular genetics, said that by using thiazole antibiotics in combination with well-known proteasome inhibitors, "we may see a synergy that allows us to markedly reduce the dose of any one of these drugs and still effectively kill the cancer cells."

More information

Read more about cancer treatments at the U.S. National Cancer Institute.

SOURCE: University of Illinois at Chicago, news release, Aug. 11, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com